ALBAN CARLOS 4

What Happened

• Alban Carlos, a director of Solventum Corp (ticker: SOLV), received an award of 3,300 restricted stock units (RSUs) on May 15, 2026. The Form 4 records this as a derivative acquisition at an acquisition price of $0.00.
• Each RSU represents a contingent right to receive one share of Solventum common stock upon settlement. According to the filing, the RSUs will fully vest on May 15, 2027, subject to Carlos’s continued service through that date. This is an equity award (grant), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-05-15; Filing date (Form 4): 2026-05-18 (Accession: 0001474632-26-000008).
• Award: 3,300 RSUs; Acquisition price reported: $0.00 (derivative).
• Vesting: RSUs fully vest on 2027-05-15, contingent on continued service (Footnotes F1 & F2).
• Shares owned following the transaction: not specified in the filing.
• No 10b5-1 plan, tax-withholding, or late-filing flag noted in the filing itself.

Context

• RSU grants are common compensation for directors and executives and represent a future right to shares if vesting conditions are met; they are not an immediate purchase of stock and do not necessarily signal immediate bullish trading by the insider.
• For retail investors, outright open-market purchases by insiders are often more informative about near-term insider conviction than time‑vested awards; track the vesting date (2027-05-15) if you want to watch for future share issuance or potential sales after vesting.